Guanidino compounds inhibit nitric oxide release in J774A.1 macrophages

Pharmacologyonline

Volumn 2, Issue , 2013, Pages 60-67

  Marzocco, Stefania ^a   Adesso, Simona ^a   Autore, Giuseppina ^a  

^a UNIVERSITY OF SALERNO   (Italy)

Author keywords

Guanidino compounds; Macrophages. LPS; Nitric oxide

Indexed keywords

CREATINE; CREATININE; GUANIDINE; GUANIDINE DERIVATIVE; INDUCIBLE NITRIC OXIDE SYNTHASE; METHYLGUANIDINE; NITRIC OXIDE;

ANIMAL CELL; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CELL VIABILITY; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVATION; ENZYME INHIBITION; IMMUNE RESPONSE; IMMUNOREACTIVITY; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN EXPRESSION; UREMIA;

EID: 84884546927     PISSN: None     EISSN: 18278620     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Vanholder R, Argilés A, Baurmeister U, Brunet P, Clark W, Cohen G, De Deyn PP, Deppisch R, Descamps-Latscha B, Henle T, Jorres A, Massy ZA, Rodriguez M, Stegmayr B, Stenvinkel P, Wratten ML. Uremic toxicity: present state of the art. Int J Artif Organs 2001; 24: 695-725
2. Raff AC, Meyer TW, Hostetter TH. New insights into uremic toxicity. Curr Opin Nephrol Hypertens 2008; 17: 560-565
3. Di Micco L, Marzocco S, Sirico ML, Torraca S, Di Iorio B. Does daily dialysis improve hypertension in chronic haemodialysis patients? Current Hypertension Reviews ISSN 2012; 8: 291-295
4. Wen CP, Cheng TY, Tsai MK, Chang YC, Chan HT, Tsai SP, Chiang PH, Hsu CC, Sung PK, Hsu YH, Wen SF. All-cause mortality attributable to chronic kidney disease: A prospective cohort study based on 462 293 adults in Taiwan. Lancet 2008; 371: 2173-2182
5. Drey N, Roderick P, Mullee M, Rogerson M. A populationbased study of the incidence and outcomes of diagnosed chronic kidney disease. Am. J. Kidney Dis 2003; 42: 677-684
6. Kato S, Chmielewski M, Honda H, Pecoits-Filho R, Matsuo S, Yuzawa Y, Tranaeus A, Stenvinkel P, Lindholm, B. Aspects of immune dysfunction in end-stage renal disease. Clin J.Am Soc Nephrol 2008; 3: 1526-1533
7. Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, Fok M, McAlister F, Garg AX. Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol 2006; 17, 2034-2047
8. Hauser AB, Stinghen AE, Kato S, Bucharles S, Aita C, Yuzawa Y, Pecoits-Filho R. Characteristics and causes of immune dysfunction related to uremia and dialysis. Perit Dial Int 2006;28:S183-7
9. Libetta C, Sepe V, Esposito P, Galli F, Dal Canton A. Oxidative stress and inflammation: Implications in uremia and hemodialysis. Clin Biochem 2011; 44: 1189-1198
10. Popolo A, Autore G, Pinto A, Marzocco S. Oxidative stress in cardiovascular and renal disease. Free Radic Res 2013; 47: 346-56
11. Cohen G., Hörl W. H. Immune Dysfunction in Uremia-An Update Toxins 2012; 4: 962-990
12. Autore G, Marzocco S, Sorrentino R, Mirone V, Baydoun A, Pinto A. In vitro and in vivo TNFa synthesis by methylguanidine, an uremic catabolyte. Life Sciences. 1999, 65: 121-12
13. Marzocco S, Di Paola R, Serraino I, Sorrentino R, Meli R, Mattaceraso G, Cuzzocrea S, Pinto A, Autore G. Effect of methylguanidine in carrageenan-induced acute inflammation in the rats. Eur. J. Pharmacol 2004; 484: 341-350
14. Marzocco S, Di Paola R, Genovese T, Sorrentino R, Britti D, Scollo G, Pinto A, Cuzzocrea S, Autore G. Methylguanidine reduces the development of non septic shock induced by zymosan in mice. Life Sci 2004; 75:1417-33
15. Marzocco S, Di Paola R, Ribecco MT, Sorrentino R, Domenico B, Genesio M, Pinto A, Autore G, Cuzzocrea S. Effect of methylguanidine in a model of septic shock induced by LPS. Free Radical Res 2004; 38: 1143-53
16. Yokozawa T., Fujitsuka N., Oura H. Production of methylguanidine from creatinine in normal rats and rats with renal failure. Nephron 1990; 56: 249-254
17. Mendes-Ribeiro A.C., Roberts N.B., Lane C., Yaqoob M., Ellory J.C. Accumulation of the endogenous L-arginine analogue NG-monomethyl-L-arginine in human end-stage renal failure patients on regular haemodialysis. Exp Physiol 1996; 81:475-81
18. Giovanetti S, Bigini M, Balestri PL, Navalesi R, Piagnoni P, De Matticis A, Ferro-Milone P, Perfetti C. Uraemia-like syndrome in dogs chronically intoxicated with methylguanidine and creatinine. Clin Sci 1965; 36: 445-452
19. Jones JD, Burnett PC. Creatinine metabolism in humans with decreased renal function: creatinine deficit. Clin Chem. 1974; 20: 1204-12
20. Deenitchina SS, Ando T, Okuda S, Kinukawa N, Hirakata H, Nagoshima A, Fujishima M. Cellular immunity in hemodialysis patients: a quantitative analysis of immune cell subsets by flow cytometry. Am J Nephrol 1995;15: 57-65
21. Vanholder R., De Smet R. Pathophysiologic Effects of Uremic Retention Solutes. Am Soc Nephrol 1999; 10: 1815-1823
22. Marzocco S, Popolo A, Bianco G, Pinto A, Autore G. Proapoptotic effect of methylguanidine on hydrogen peroxidetreated rat glioma cell line. Neurochem Int 2010; 57: 518-24
23. Cioffi G, Dal Piaz F, De Caprariis P, Sanogo R, Marzocco S, Autore G, De Tommasi N. Antiproliferative triterpene saponins from Entada africana. J Nat Prod 2006; 69: 1323-9
24. Ben Jemia M, Kchouk ME, Senatore F, Autore G, Marzocco S, De Feo V, Bruno M. Antiproliferative activity of hexane extract from Tunisian Cistus libanotis, Cistus monspeliensis and Cistus villosus. Chem Cent J 2013; 5:7-47
25. Bianco G, Russo R, Marzocco S, Velotto S, Autore G., Severino L. Modulation of macrophage activity by aflatoxins B1 and B2 and their metabolites aflatoxins M1 and M2. Toxicon 2012; 59: 644-50
26. Cianchi F, Cuzzocrea S, Vinci MC, Messerini L, Comin CE, Navarra G, Perigli G, Centorrino T, Marzocco S, Lenzi E, Battisti N, Trallori G, Masini E. Heterogeneous expression of cyclooxygenase-2 and inducible nitric oxide synthase within colorectal tumors: correlation with tumor angiogenesis. Dig Liver Dis 2010; 42: 20-7
27. Bianco G, Fontanella B, Severino L, Quaroni A, Autore G, Marzocco S. Nivalenol and deoxynivalenol affect rat intestinal epithelial cells: a concentration related study. PLOS One 2012;7(12) art. no. e52051
28. Parrillo, J.E. Pathogenetic mechanisms of septic shock, N. Engl. J. Med 1993; 328: 1471-1477
29. Holmes C.L. and Walley K.R. The evaluation and management of shock, Clin. Chest Medv 2003; 24: 775-789
30. Paul P. Tak and Gary S. Firestein NF-êB: a key role in inflammatory diseases. J Clin Invest 2001; 107: 7-11
31. Stenvinkel P, Pecoits-Filho R, Lindholm B. Coronary artery disease in end-stage renal disease: no longer a simple plumbing problem. J Am Soc Nephrol 2003; 14:1927-39
32. Cohen G, Glorieux G, Thornalley P, Schepers E, Meert N, Jankowski J, Jankowski V, Argiles A, Anderstam B, Brunet P, Cerini C, Dou L, Deppisch R, Marescau B, Massy Z, Perna A, Raupachova J, Rodriguez M, Stegmayr B, Vanholder R, Hörl WH. Review on uraemic toxins III: recommendations for handling uraemic retention solutes in vitro towards a standardized approach for research on uraemia. Nephrol Dial Transplant 2007; 22: 3381-90
33. Marzocco S, Di Paola R, Ribecco MT, Sorrentino R, Britti D, Genesio M, Pinto A, Autore G, Cuzzocrea S. Effect of Methylguanidine in a Model of Septic Shock Induced by LPS. Free Radical Research 2004; 38:11,1143-1153
34. Dugo L, Marzocco S, Mazzon E, Di Paola R, Genovese T, Caputi AP, Cuzzocrea S. Effects of GW274150, a novel and selective inhibitor of iNOS activity, in acute lung inflammation. Br J Pharmacol 2004; 141: 979-87
35. Vanholder R, De Smet R, Glorieux G, Argiles A, Baurmeister U, Brunet P, Clark, Cohen G, De Deyn PP, Deppisch R, et al. Review on uremic toxins: Classification, concentration, and interindividual variability. Kidney Int 2003;63: 1934-1943
36. Duranton F, Cohen G, De Smet R, Rodriguez M, Jankowski J, Vanholder R, Argiles A. Normal and Pathologic Concentrations of Uremic Toxins. J. Am. Soc. Nephrol 2012; 23: 1258-1270
37. Vanholder R, Schepers E, Pletinck A, Neirynck N, Glorieux G. An update on protein-bound uremic retention solutes. J. Ren Nutr 2012; 22: 90-94
38. Marzocco S, Dal Piaz F, Di Micco L, Autore G, Torraca S, Sirico ML, Tartaglia D, Di Iorio B. Very low protein diet reduces Indoxjl Sulphate levels in Chronic kidney Disease. Blood Purif 2013; 13: 35: 196-201
39. Vanholder, R, Baurmeister U, Brunet P, Cohen G, Glorieux G, Jankowski J. A bench to bedside view of uremic toxins. J. Am. Soc. Nephrol 2008; 19: 863-870